|
Author
Jaber, Abbas Hassan
Chennagiri, Koushik
|
Abstract
The need for Pharmaceutical products has been going along the human kind from the `discovery of the first disease and it was necessary to produce the pharmaceutical items not just for health purposes but for the beauty care, in a large scale considering the increasing population on the globe.
I-Dositecno was established in 2005, in Barcelona, with the vision of leading the pharmaceutical industry with the high precision and autotomised production equipment to maintain the best quality products to the Market. I-Dositecno has a sales value of 5 Million Euros and is increasing gradually every year from the day of establishment with the constant efforts and dedication.
In I-Dositechno they design and build sterile and aseptic filling machinery suited for oncology, biotechnology, biosimilars and ophthalmological products with a great variety of formats (vials, syringes, cartridges, eye-drops and Aptar devices). From their beginnings 15 years ago, i-Dositecno has developed a complete range of machinery, giving to the pharmaceutical market a way of work, with fully servo motorized machine, in order to facilitate the format changes and optimize the production.
With over 15 years’ experience, the company is actually selling worldwide, always through associated companies, to give proximity and added value to all of the installations. The company employees about 48 in total in Barcelona Head Quarters.
Our challenge, as students of masters in International Marketing, is to study the Indian market for the company and prepare a marketing plan that could help the company to have a better market share in India. I-Dositecno think that the Indian market in an opportunity, since the pharmaceutical industry in India was valued at US$33 billion in 2017, growing 9.4 per cent year-on-year and generic drugs account for 20 per cent of global exports in terms of volume, making the country the largest provider of generic medicines globally. In addition, the government encourage the growth of drug manufacturing by Indian companies; companies carved a niche in both the Indian and world markets with their expertise in reverse-engineering new processes for manufacturing drugs at low costs which became the advantage for industry to reduce the costs of manufacturing, letting the Indian companies to have a big market all around the world
|
|
